Phil Johnson
Vorstandsvorsitzender bei Interius BioTherapeutics, Inc.
Aktive Positionen von Phil Johnson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | - |
| Gründer | 01.01.2016 | - | |
Interius BioTherapeutics, Inc.
 Interius BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Interius BioTherapeutics, Inc. is a biopharmaceutical company that targets cancer. The company was founded by Saar Gill and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
| Vorstandsvorsitzender | 01.01.2020 | - | |
| Präsident | 01.01.2020 | - |
Karriereverlauf von Phil Johnson
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Limelight Bio, Inc.
Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Interius BioTherapeutics, Inc.
Interius BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Interius BioTherapeutics, Inc. is a biopharmaceutical company that targets cancer. The company was founded by Saar Gill and is headquartered in Philadelphia, PA. | Health Technology |
- Börse
- Insiders
- Phil Johnson
- Erfahrung